NYSE: SYK
Stryker Corp Stock

SYK Price
$205.39
Fair Value Price
N/A
Market Cap
$77.10B
52 Week Low
$126.50
52 Week High
$225.63
P/E
47.99x
P/B
6.05x
P/S
4.81x
PEG
1.41x
Dividend Yield
1.09%%
Revenue
$14.07B
Earnings
$1.60B
Gross Profit Margin
63.3%%
Operating Margin
14.36%%
Net Profit Margin
11.4%%
Debt to Equity
1.47
Operating Cash Flow
$3B
Beta
1.04
Next Earnings
N/A
Ex-Dividend
Sep 29, 2020
Next Dividend
Oct 30, 2020

Zen Score

High
Medium
Low
37
Industry average

Reasons for this score

SYK ($205.39) is trading below its intrinsic value of $520.67, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
SYK is poor value based on its earnings relative to its share price (47.99x), compared to the US market average (46.84x)
Valuation
SYK is good value based on its earnings relative to its share price (47.99x), compared to the US Medical Devices industry average (89.93x)
Valuation

1 of 13

SYK News

Valuation

SYK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
47.99x
Industry
89.93x
Market
46.84x
SYK is poor value based on its earnings relative to its share price (47.99x), compared to the US market average (46.84x)
Valuation
SYK is good value based on its earnings relative to its share price (47.99x), compared to the US Medical Devices industry average (89.93x)
Valuation

SYK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.05x
Industry
10.43x
Market
63.22x
SYK is good value based on its book value relative to its share price (6.05x), compared to the US market average (63.22x)
Valuation
SYK is good value based on its book value relative to its share price (6.05x), compared to the US Medical Devices industry average (10.43x)
Valuation

SYK price to earnings growth (PEG)

For valuing profitable companies with growth potential
SYK is poor value relative to its rate of earnings growth, measured by PEG ratio (1.41x)
Valuation

SYK's financial health

Profit margin

Revenue
$3.6B
Net Income
$493.0M
Profit Margin
13.7%%
SYK's Earnings (EBIT) of $2.02B can safely cover interest payments on company debt ($12.92B)
Financials
SYK's profit margin has decreased (-13.6%%) in the last year from (25%%) to (11.4%%)
Financials

Assets to liabilities

Assets
$29.4B
Liabilities
$16.3B
Debt to equity
0.8
SYK's short-term assets ($12.80B) exceed its short-term liabilities ($4.41B)
Financials
SYK's long-term liabilities ($14.32B) exceed its short-term assets ($12.80B)
Financials
SYK's debt has increased relative to shareholder equity (1.47), over the past 5 years ago (0.98)
Financials
SYK's debt to equity ratio (1.47) is considered high
Financials

Cash flow

Operating
$591.0M
Investing
-$163.0M
Financing
-$768.0M
SYK's operating cash flow ($2.58B) may not be sufficient to safely service the company's debt ($12.92B)
Financials

Stryker Corp Stock FAQ

(NYSE: SYK) Stryker Corp trades on the NYSE under the ticker symbol SYK. Stryker Corp stock quotes can also be displayed as NYSE: SYK.
(NYSE: SYK) Stryker Corp stock price per share is $205.39 today (as of Oct 29, 2020).
(NYSE: SYK) Stryker Corp's 52-week high was $225.63, and its 52-week low was $126.50. It is currently -8.97%% from its 52-week high and 62.36%% from its 52-week low.
(NYSE: SYK) Stryker Corp's market cap is $77.10B, as of Oct 30, 2020.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Stryker Corp's market cap is calculated by multiplying SYK's current stock price of $205.39 by SYK's total outstanding shares of 375,378,477.
(NYSE: SYK) Stryker Corp currently has 375,378,477 outstanding shares. With Stryker Corp stock trading at $205.39 per share, the total value of Stryker Corp stock (market capitalization) is $77.10B.

Stryker Corp stock was originally listed at a price of $9.31 in Dec 31, 1997. If you had invested in Stryker Corp stock at $9.31, your return over the last 22 years would have been 2,105.41%%, for an annualized return of 15.1%%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics